BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced the appointment of John Yates, MB ChB, MD, to the newly created position of Chief Medical Officer. Dr. Yates will oversee the medical strategy and clinical development of Array’s cancer and inflammation pipeline.
